APA (7th ed.) Citation

Ping, F., Wang, X., Yang, J., Zhou, M., Li, W., Xu, L., & Li, Y. Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients without Overt Diabetes Evaluated by 1H-Magnetic Resonance Spectroscopy. Wiley.

Chicago Style (17th ed.) Citation

Ping, Fan, Xuan Wang, Jing Yang, Mei-cen Zhou, Wei Li, Ling-ling Xu, and Yu-xiu Li. Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients Without Overt Diabetes Evaluated by 1H-Magnetic Resonance Spectroscopy. Wiley.

MLA (9th ed.) Citation

Ping, Fan, et al. Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients Without Overt Diabetes Evaluated by 1H-Magnetic Resonance Spectroscopy. Wiley.